Quantum Genomics Announces Interim Analysis from Study of Firibastat in Renal Failure Patients

Firibastat could be used in hypertensive and heart failure patients with concomitant renal dysfunction, subject to dose adjustment.

Previous Post (p) Quantum Genomics Provides Update on the Impact of the COVID-19 Health Crisis on Clinical Research Activities

Next Post (n) Quantum Genomics Enrolls First Patient in Its Pivotal Phase III FRESH Trial of Firibastat in Difficult-to-treat and Resistant Hypertension